Janus Henderson Group
INBX icon

Janus Henderson Group’s Inhibrx INBX Stock Holding History

Janus Henderson Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Buy
+3,400
New +$252K ﹤0.01% 2296

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group's INBX Position: Q1 2026 in Review

Janus Henderson Group opened a new position in Inhibrx (INBX) in Q1 2026: 3,400 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #2296 among its holdings.

135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Janus Henderson Group held 3,400 shares of Inhibrx worth $229K as of Q1 2026.
  • Inhibrx was a new Janus Henderson Group position in Q1 2026.
  • Inhibrx made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2296 holding.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.